Head-to-head · Value Score
CoreAge Rx vs Sprout Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Sprout Health a 84. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameSprout Health
#15 · Grade B+ · Good Value
Est. first month
$149/mo
Save ~89% vs brand-nameFDA warning letter. The FDA issued Sprout Health Partners LLC dba Sprout Health a warning letter in September 2025. Check it on the FDA database.
Get this deal Full Sprout Health review →The verdict
CoreAge Rx takes it on Value Score, 93 to 84 — an est. $99/mo first month, with no teaser step-up baked in. Sprout Health isn't out of it: Patients who want a low compounded entry price but the option of brand-name Wegovy or Zepbound on the same account, with minimal onboarding.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Sprout Health |
|---|---|---|
| Value Score | 93 (A+) | 84 (B+) |
| Est. first month | $99/mo | $149/mo |
| Save vs brand-name | ~89% | ~89% |
| Semaglutide | $99/mo | $149/mo |
| Tirzepatide | $149/mo | $199/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Not disclosed |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Sprout Health
A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
Why it's a deal
- LegitScript-certified with a listed address and contact line
- Both compounded semaglutide and tirzepatide - advertised from $149 and $199 - and a genuine brand-name Wegovy and Zepbound route on the same account
- Low-friction intake — no labs and often no telehealth visit required
The fine print
- The FDA issued this operator a warning letter in September 2025 — it is on the public FDA warning-letter database
- Compounded semaglutide and tirzepatide are not FDA-approved
- No oral or sublingual route — injectable only
- Thin transparency — no named medical director, and state availability is quiz-gated
- The $110 rate needs a six-month plan paid as a block, so leaving early costs more than one month
- "No labs, no visit" convenience also means lighter clinical oversight
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Sprout Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.